You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Litigation for pomalidomide


✉ Email this page to a colleague

« Back to Dashboard


US Court Litigation for pomalidomide

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
10,555,939 Louisiana Health Service & Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana v. Celgene Corporation ⤷  Try a Trial 2023-09-05 15:1 Antitrust Litigation (Monopolizing Trade) District Court, S.D. New York Plaintiff ⤷  Try a Trial
10,555,939 ⤷  Try a Trial ⤷  Try a Trial 2017-05-11 2021-08-19 35:271 Patent Infringement District Court, D. New Jersey None ⤷  Try a Trial
10,555,939 CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. ⤷  Try a Trial 2019-07-12 2022-04-06 28:1338 Patent Infringement District Court, D. New Jersey None ⤷  Try a Trial
10,555,939 CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. ⤷  Try a Trial 2021-02-07 2022-04-06 35:271 Patent Infringement District Court, D. New Jersey None ⤷  Try a Trial
10,555,939 CELGENE CORPORATION v. MSN LABORATORIES PRIVATE LIMITED ⤷  Try a Trial 2022-04-06 2022-06-15 35:271 Patent Infringement District Court, D. New Jersey None ⤷  Try a Trial
10,555,939 Celgene Corporation v. Mylan Pharmaceuticals Inc. ⤷  Try a Trial 2020-11-05 2021-11-05 Court of Appeals for the Federal Circuit ⤷  Try a Trial
6,045,501 United HealthCare Services, Inc. v. Celgene Corporation DO NOT DOCKET. CASE HAS BEEN TRANSFERRED OUT. ⤷  Try a Trial 2020-03-05 2020-12-02 15:2 Antitrust Litigation District Court, D. Minnesota Plaintiff ⤷  Try a Trial
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for pomalidomide

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,635,517 Coalition for Affordable Drugs VI LLC ⤷  Try a Trial 2015-05-07 05-07-2015 Celgene Corporation Inter partes review ⤷  Try a Trial 11-16-2015 GEORGE MULLER ⤷  Try a Trial
6,045,501 Coalition For Affordable Drugs VI LLC ⤷  Try a Trial 2015-04-23 04-23-2015 Celgene Corporation Inter partes review ⤷  Try a Trial 10-27-2015 MARC ELSAYED ⤷  Try a Trial
6,315,720 Coalition for Affordable Drugs VI LLC ⤷  Try a Trial 2015-04-23 04-23-2015 Celgene Corporation Inter partes review ⤷  Try a Trial 10-27-2015 Bruce Williams ⤷  Try a Trial
6,315,720 Coalition for Affordable Drugs VI LLC ⤷  Try a Trial 2015-04-23 04-23-2015 Celgene Corporation Inter partes review ⤷  Try a Trial 10-27-2015 Bruce Williams ⤷  Try a Trial
6,315,720 Coalition for Affordable Drugs VI LLC ⤷  Try a Trial 2015-04-23 04-23-2015 Celgene Corporation Inter partes review ⤷  Try a Trial 10-27-2015 Bruce Williams ⤷  Try a Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.